These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 11363640

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. FDA approves first new class of HIV drugs. Food and Drug Administration.
    AIDS Alert; 1996 Aug; 11(8):89. PubMed ID: 11363655
    [Abstract] [Full Text] [Related]

  • 3. Nevirapine triple combo results released.
    Common Factor; 1995 Apr; (no 10):21. PubMed ID: 11362346
    [Abstract] [Full Text] [Related]

  • 4. Nevirapine approval expands combo possibilities--and HIV suppression.
    Vazquez E.
    Posit Aware; 1996 Apr; 7(5):9. PubMed ID: 11363791
    [Abstract] [Full Text] [Related]

  • 5. Nevirapine: new drug, new class, new questions.
    Mascolini M.
    J Int Assoc Physicians AIDS Care; 1996 Jul; 2(7):8-13. PubMed ID: 11363750
    [Abstract] [Full Text] [Related]

  • 6. Nevirapine recommended for approval.
    BETA; 1996 Jun; ():6-7. PubMed ID: 11363650
    [Abstract] [Full Text] [Related]

  • 7. New combo trial/same old style.
    Gilden D.
    GMHC Treat Issues; 1995 Apr; 9(4):9. PubMed ID: 11362369
    [Abstract] [Full Text] [Related]

  • 8. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [Abstract] [Full Text] [Related]

  • 9. Nevirapine--first of a new class of drugs.
    PI Perspect; 1996 Sep; (No 19):9-10. PubMed ID: 11363907
    [Abstract] [Full Text] [Related]

  • 10. Nevirapine expanded access.
    Posit Aware; 1996 Sep; 7(2):5. PubMed ID: 11363363
    [Abstract] [Full Text] [Related]

  • 11. New double vs. triple antiviral combination study, CD4 200-500, no prior treatment.
    James JS.
    AIDS Treat News; 1995 Dec 01; (no 236):7. PubMed ID: 11363052
    [Abstract] [Full Text] [Related]

  • 12. Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus.
    Cheeseman SH, Havlir D, McLaughlin MM, Greenough TC, Sullivan JL, Hall D, Hattox SE, Spector SA, Stein DS, Myers M.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb 01; 8(2):141-51. PubMed ID: 7530585
    [Abstract] [Full Text] [Related]

  • 13. Nevirapine approved by FDA. Food and Drug Administration.
    Bowersox J.
    NIAID AIDS Agenda; 1996 Sep 01; ():10. PubMed ID: 11363918
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of once-daily combination therapy with didanosine, lamivudine and nevirapine in antiretroviral-naive HIV-infected patients.
    Ribera E, Rodríguez-Pardo D, Rubio M, Soler A, Pedrol E, Blanco JL, González A, Crespo M, Falcó V, Ocaña I, Deig E, Miró JM, Pahissa A.
    Antivir Ther; 2005 Sep 01; 10(5):605-14. PubMed ID: 16152754
    [Abstract] [Full Text] [Related]

  • 15. FDA advisory committee deadlocks on delavirdine. Food and Drug Administration.
    Mascolini M.
    AIDS Treat News; 1996 Dec 06; (No 260):3-5. PubMed ID: 11364022
    [Abstract] [Full Text] [Related]

  • 16. FDA looks at full approval for d4T. Food and Drug Administration.
    Posit Aware; 1996 Dec 06; 7(1):7. PubMed ID: 11363131
    [Abstract] [Full Text] [Related]

  • 17. Update on nevirapine: quest for a niche.
    MacDougall DS.
    J Int Assoc Physicians AIDS Care; 1997 Sep 06; 3(9):37-43. PubMed ID: 11364713
    [Abstract] [Full Text] [Related]

  • 18. AZT plus 3TC produces best results to date.
    Grodeck B.
    Posit Aware; 1995 Sep 06; ():6. PubMed ID: 11362209
    [Abstract] [Full Text] [Related]

  • 19. Three-drug combos.
    Posit Aware; 1996 Sep 06; 7(1):6. PubMed ID: 11363125
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.